BillsHH.R. 9661
To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
Stage
In committee
Latest action
Referred to the House Committee on Energy and Commerce.
July 14, 2026
Committees
- PrimaryEnergy and Commerce Committee
Action history
- July 14, 2026Introduced in House
- July 14, 2026Introduced in House
- July 14, 2026Referred to the House Committee on Energy and Commerce.